UK Department for International Trade to Support and Participate in VB100 Global Healthcare Innovation Roadshow

/

For many years, the United Kingdom has remained the most popular destination for foreign direct investment (FDI) among European countries; Forbes has also ranked the UK as one of the best countries in the world to do business.The UK’s transparent flat tax rate of 19% is not only the lowest among the G7 nations but also one of the lowest within the G20. The UK has also introduced various preferential tax regimes. For instance, the “Patent Box” regime reduces the corporate income tax rate for eligible companies, levying only a 10% tax on profits derived from qualifying patented inventions. Meanwhile, schemes such as Research and Development (R&D) tax credits provide allowances equivalent to 230% and 13% of qualifying R&D expenditures for small and medium-sized enterprises (SMEs) and large companies, respectively.

As one of the world’s three major life sciences hubs, the UK’s medtech industry is experiencing rapid growth.Currently, the UK is home to more than 4,000 medtech companies, with annual revenues exceeding £26.5 billion, and all of the top 30 global medical technology companies have operations in the country. Among the world’s top five universities for preclinical, clinical, and health sciences, three are located in the UK. Medical innovations such as DNA sequencing, MRI, CT technology, and in vitro fertilization (IVF) all originated in the UK, where innovators have won more than 80 Nobel Prizes in life sciences.

The UK government’s strong support has provided a continuous impetus for innovative development in the medical technology sector.The UK government has invested £826 million in the research, development, and production of COVID-19 vaccines, therapeutics, and related treatments; an additional £3 billion has been allocated to address “grand challenges,” including artificial intelligence, data utilization, and healthy aging. Furthermore, to support the long-term development of the National Health Service (NHS), the UK government has established a long-term initiative with funding of up to £20 billion.

In the field of medical devices, cooperation between the United Kingdom and China has yielded substantial achievements.In response to the challenges posed by the COVID-19 pandemic, the Department of Engineering Science at the University of Oxford and the Oxford Institute for Advanced Study (Suzhou) jointly developed a rapid ribonucleic acid (RNA) detection method capable of determining whether an individual is infected within 30 minutes, without the need for specialized equipment. Mindray Medical, China’s largest medical device manufacturer, established its UK subsidiary in 2005 and currently serves over 500 British clients, including Royal Papworth Hospital and Sunderland City Hospital. The UK has become Mindray’s fastest-growing overseas market, with annual sales growth ranging from 15% to 20%. In recognition of the UK’s favorable business environment, Mindray has also designated the country as the European headquarters for its finance and human resources operations.

For more information on the UK life sciences and healthcare industry, please click「https://healthcare.ukbusinessinchina.com/」, visit the official Life Sciences and Healthcare platform of the UK Department for International Trade.

At the 2022 6th Future Healthcare Top 100 Conference, VB100 and VCBeat will collaborate with multiple countries’ consulates in China to jointly host a global roadshow for innovative healthcare projects. Each country will have its own dedicated session. Building on the continued effort to connect venture capital investors with entrepreneurs and facilitate exchanges between healthcare companies and leading investment firms, this initiative aims to enrich the international healthcare venture capital ecosystem. During this event,The UK government will provide support and participate in the second day’s global healthcare innovation project pitch session. The UK Department for International Trade will dispatch representative officials to introduce the business environment of the UK healthcare industry, invite innovative UK enterprises to present their projects and engage in a Q&A session, showcase corporate innovative technologies, and explore investment and cooperation opportunities between the UK and China in the healthcare sector.

The Global Healthcare Innovation Project Roadshow is a specialized communication platform established by the Future Healthcare 100 Conference for outstanding innovative projects and investment institutions both domestically and internationally. Committed to bridging venture capital investors and entrepreneurs, and facilitating exchanges between healthcare enterprises and leading investment firms, it enriches the global ecosystem of healthcare venture capital dialogue and provides a public showcase for premier healthcare innovation projects worldwide.

2022Global Healthcare Innovation ProjectsRoadshow Time: Day 2 of the Future Healthcare Top 100 Conference, to be held at the Suzhou Shishan International Conference Center. For more details about this roadshow, please continue to follow the VB100 official WeChat account. Investors interested in various sub-sectors of healthcare are welcome to register and participate in the roadshow.

Investors: Scan QR Code to Register

Registration Link: https://vb100.mike-x.com/xum8e

/

Conference Dates: Late May or Early June 2022

Venue: Shishan International Convention Center, Suzhou, China

Limited-Time Offer: Conference All-Access Pass

Purchase Channels:Search for the “VB100” mini program on WeChat to make a purchase.

Two types of general admission passes are available for public purchase at this conference:

RMB 899 [VB100 All-Access Pass, Meals Not Included]RMB 1,299 [Includes Meals & VB100 All-Access Pass],Limited-Time Offer · Conference All-Access PassSave ¥630 off the original price, now as low as ¥269Start:

Your trust will grant you the following benefits:

1. All-Access Pass for Forum + Exhibition + Interactive Activities (Separate registration required for certain segments, such as LPGP)

2. On-site Resource Coordination Group

3. Guest-authorized PPTs, conference proceedings, public reports, and other restricted materials

4. Lunch vouchers during the conference (only for tickets including meals)

Special Note:

1. Duration of This Limited-Time OfferUpdates on Key Milestones from Today Until the Next Meeting;

2. Ticket prices will be adjusted as information regarding the conference theme, speakers, topics, and exhibitors is unveiled,For every 100-yuan increase, until the original price is restored;

3、Upon the conclusion of this limited-time offer,Ticket prices will rise to 369 yuan.Onset

Scan the QR code to register for the 2022·6th Future Healthcare Top 100 Conference

2022 Future Healthcare Top 100 Conference Consultation